KR850000400A - 피리딘 유도체 - Google Patents

피리딘 유도체 Download PDF

Info

Publication number
KR850000400A
KR850000400A KR1019840003526A KR840003526A KR850000400A KR 850000400 A KR850000400 A KR 850000400A KR 1019840003526 A KR1019840003526 A KR 1019840003526A KR 840003526 A KR840003526 A KR 840003526A KR 850000400 A KR850000400 A KR 850000400A
Authority
KR
South Korea
Prior art keywords
bis
pyridine
methoxyphenyl
pharmaceutically acceptable
compound
Prior art date
Application number
KR1019840003526A
Other languages
English (en)
Other versions
KR860001602B1 (ko
Inventor
마쯔모도 켄 (외 4)
Original Assignee
아더 알. 웨일
일라이 릴리 앤드 캄파니
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 아더 알. 웨일, 일라이 릴리 앤드 캄파니 filed Critical 아더 알. 웨일
Publication of KR850000400A publication Critical patent/KR850000400A/ko
Application granted granted Critical
Publication of KR860001602B1 publication Critical patent/KR860001602B1/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/30—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pain & Pain Management (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

내용 없음.

Description

피리인 유도체
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (7)

  1. 다음 일반식(IV) 화합물을 하이드록실아민 또는 그의 염과 함께 반응시키거나, R가 요오드인 다음 일반식(I) 화합물을 비스(트리플루오로메틸)수은과 N-메틸-2-필로리디논과 함께 반응시켜서 R가 트리플루오로메틸인 일반식(I)화합물을 수득하거나, 일반식(I) 화합물을 염으로 전환시키는 것을 특징으로하여 일반식(I)의 화합물 또는 그의 약제학적으로 허용되는 염을 제조하는 방법.
    상기 일반식에서, R는 수소, 트리플루오로메틸, 플루오로, 클로로, 블로모 또는 요오드이다.
  2. 제1항에 있어서, 6-(4-플루오로페닐)-2,3-비스-(4-메톡시페닐)피리딘 또는 그의 약학적으로 허용되는 염제조에 이용되는 방법.
  3. 제1항에 있어서, 6-(4-클로로페닐)-2,3-비스(4-메톡시페닐) 피리딘 또는 그의 약학적으로 허용되는 염 제조에 이용되는 방법.
  4. 제1항에 있어서, 6-(4-블로모페닐)-2,3-비스-(4-메톡시페닐) 피리딘 또는 그의 약학적으로 허용되는 제조에 이용되는 방법.
  5. 제1항에 있어서, 6-(4-트리플루오로메틸페닐)-2,3-비스(4-메톡시페닐) 피리딘 또는 약학적으로 허용되는 염 제조에 이용되는 방법.
  6. 제1항에 있어서, 6-(4-요오도페닐)-2,3-비스(4-메톡시페닐) 피리딘 또는 약학적으로 허용되는 염제조에 이용되는 방법.
  7. 제1항에 있어서, 6-페닐-2,3-비스(4-메톡시페닐) 피리딘 제조에 이용되는 방법.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019840003526A 1983-06-22 1984-06-22 피리딘 유도체의 제조방법 KR860001602B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US506933 1983-06-22
US06/506,933 US4533666A (en) 1983-06-22 1983-06-22 6-Phenyl-2,3-bis-(4-methoxyphenyl)-pyridine derivatives having anti-inflammatory activity
US506,933 1983-06-22

Publications (2)

Publication Number Publication Date
KR850000400A true KR850000400A (ko) 1985-02-27
KR860001602B1 KR860001602B1 (ko) 1986-10-13

Family

ID=24016558

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019840003526A KR860001602B1 (ko) 1983-06-22 1984-06-22 피리딘 유도체의 제조방법

Country Status (9)

Country Link
US (1) US4533666A (ko)
EP (1) EP0130044A1 (ko)
JP (1) JPS6013759A (ko)
KR (1) KR860001602B1 (ko)
DK (1) DK300784A (ko)
GB (1) GB2142023B (ko)
GR (1) GR82377B (ko)
HU (1) HU192560B (ko)
IL (1) IL72145A0 (ko)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5171737A (en) * 1989-03-03 1992-12-15 The Liposome Company, Inc. Emulsions
US5686470A (en) * 1995-02-10 1997-11-11 Weier; Richard M. 2, 3-substituted pyridines for the treatment of inflammation
US6515014B2 (en) 1995-06-02 2003-02-04 G. D. Searle & Co. Thiophene substituted hydroxamic acid derivatives as cyclooxygenase-2 and 5-lipoxygenase inhibitors
US6512121B2 (en) 1998-09-14 2003-01-28 G.D. Searle & Co. Heterocyclo substituted hydroxamic acid derivatives as cyclooxygenase-2 and 5-lipoxygenase inhibitors
CA2223154A1 (en) 1995-06-02 1996-12-05 G.D. Searle & Co. Heterocyclo substituted hydroxamic acid derivatives as cyclooxygenase-2 and 5-lipoxygenase inhibitors
US6677364B2 (en) 1998-04-20 2004-01-13 G.D. Searle & Co. Substituted sulfonylphenylheterocycles as cyclooxygenase-2 and 5-lipoxygenase inhibitors
US6174901B1 (en) 1998-12-18 2001-01-16 Amgen Inc. Substituted pyridine and pyridazine compounds and methods of use
US20030105144A1 (en) 2001-04-17 2003-06-05 Ping Gao Stabilized oral pharmaceutical composition
US6956132B2 (en) * 2001-08-03 2005-10-18 Ishihara Sangyo Kaisha. Ltd. Process for producing 2-phenylacetophenone derivatives and precursors therefor
EP1492784A4 (en) * 2002-03-28 2006-03-29 Merck & Co Inc SUBSTITUTED 2,3-DIPHENYLPYRIDINES
US7329401B2 (en) * 2002-04-15 2008-02-12 The Regents Of The University Of California Cyclooxygenase-2 selective agents useful as imaging probes and related methods
WO2004094379A2 (en) * 2003-04-16 2004-11-04 Amgen Inc. 3-phenyl-4- (pyrimidin-2-yl) -6- (piperidin-4-yl) derivatives and related compounds as tnf-alpha and il-1 inhibitors for the treatment of inflammations
US11066398B2 (en) * 2013-12-11 2021-07-20 The Scripps Research Institute Small molecule c-Myc inhibitors
US11791748B2 (en) 2019-07-24 2023-10-17 Tdk Corporation Smart wheel energy harvester

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2416295C3 (de) * 1974-04-04 1980-01-10 Studiengesellschaft Kohle Mbh, 4330 Muelheim Verfahren zur Herstellung von ein- oder mehrfach substituierten Pyridinen durch katalytische Mischcyclisierung von Alkinen mit Nitrilen in Gegenwart einer Kobalt-Komplexverbindung
US4153703A (en) * 1977-06-30 1979-05-08 Uniroyal, Inc. Method of controlling insects and acarids with certain aryl-substituted thiazoles
US4197306A (en) * 1977-06-30 1980-04-08 Uniroyal, Inc. Aryl-substituted thiazoles
US4168315A (en) * 1977-09-28 1979-09-18 The Upjohn Company Dianisyl thiazole compound, compositions and method of antithrombotic treatment
EP0005219B1 (en) * 1978-04-24 1981-07-22 A/S Dumex (Dumex Ltd.) Arylimidazoles, their synthesis and pharmaceutical or veterinary preparations containing them
US4322428A (en) * 1980-04-02 1982-03-30 Eli Lilly And Company 2(4-Fluorophenyl)-4,5,-bis(4-methoxyphenyl)thiazole and method of use
US4330552A (en) * 1980-11-06 1982-05-18 E. I. Du Pont De Nemours And Company Antiinflammatory 4,5-diaryl-2-arylthioimidazoles

Also Published As

Publication number Publication date
GB2142023A (en) 1985-01-09
IL72145A0 (en) 1984-10-31
HUT34449A (en) 1985-03-28
GB2142023B (en) 1986-10-08
HU192560B (en) 1987-06-29
JPS6013759A (ja) 1985-01-24
DK300784D0 (da) 1984-06-20
GB8415819D0 (en) 1984-07-25
GR82377B (ko) 1984-12-13
KR860001602B1 (ko) 1986-10-13
US4533666A (en) 1985-08-06
EP0130044A1 (en) 1985-01-02
DK300784A (da) 1984-12-23

Similar Documents

Publication Publication Date Title
KR850000400A (ko) 피리딘 유도체
KR860001110A (ko) 항균제 ⅱ의 제법
DK142985A (da) Redox-indikatorer
KR840005083A (ko) 항고혈압제로서 유용한 아미노산유도체의 제조방법
KR830001269A (ko) 치환 프로린의 메르캅토 아실 유도체의 제조방법
KR830006228A (ko) 이미다졸 유도체의 제조방법
KR890013049A (ko) 2',3'-디에옥시-2',2'-디플루오로뉴클레오사이드
KR870008824A (ko) 디플루오로할로메톡시페닐 유도체 및 그것을 유효성분으로 함유하는 살비제(殺碑制)
DK379089A (da) Tetrahydro-1-benzoec,daaindolpropionsyre-sulfonamider, deres fremstilling og anvendelse
KR830000215A (ko) 펩타이드 유도체의 제법
FI823142A0 (fi) Foerfarande foer framstaellning av s-adenocylmetiotinderivat
KR830006255A (ko) 피페라진 유도체의 제조방법
KR850000412A (ko) 피리미딘 유도체의 제조방법
KR870003994A (ko) 도파민-β-하이드록시라제 억제제
KR840004422A (ko) 사이프로헵타딘-3-카복실산의 에스테르 및 관련 화합물의 제조방법
KR870004006A (ko) 5-아릴-2,4-디알킬-3h-1,2,4-트리아졸-3-티온 및 이의 제조 방법
KR890005076A (ko) 티아디아진 유도체, 그의 제조방법 및 그 화합물을 함유하는 살충제
DK142992C (da) Fremgangsmaade til fremstilling af steroid-17-spirolactoner eller metalsalte af den tilsvarende hydroxycarboxylsyre af den 6,7-umaettede forbindelse
KR840004720A (ko) 살충제 조성물 및 이의 제조방법
KR850000380A (ko) 터페닐 유도체의 제조방법
KR870004005A (ko) 5-나프틸-2,4-디알킬-3h-1,2,4-트리아졸-3-티온 및 이의 제조 방법
IL57555A (en) 1-trimethylsilylphenyl-3-benzoyl-urea derivatives,their production and their use as insecticides
KR850001667A (ko) 불소화 피롤리돈 유도체의 제법 및 그 조성물
KR870007913A (ko) 치환된 피리미딘 유도체의 제조방법
KR830005231A (ko) 이미다졸 유도체의 제조방법

Legal Events

Date Code Title Description
E701 Decision to grant or registration of patent right